JP2022504638A5 - - Google Patents
Info
- Publication number
- JP2022504638A5 JP2022504638A5 JP2021519747A JP2021519747A JP2022504638A5 JP 2022504638 A5 JP2022504638 A5 JP 2022504638A5 JP 2021519747 A JP2021519747 A JP 2021519747A JP 2021519747 A JP2021519747 A JP 2021519747A JP 2022504638 A5 JP2022504638 A5 JP 2022504638A5
- Authority
- JP
- Japan
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022209518A JP2023040106A (ja) | 2018-10-11 | 2022-12-27 | 統合的ストレス経路のプロドラッグ調節剤 |
| JP2025027546A JP2025081607A (ja) | 2018-10-11 | 2025-02-25 | 統合的ストレス経路のプロドラッグ調節剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862744293P | 2018-10-11 | 2018-10-11 | |
| US62/744,293 | 2018-10-11 | ||
| PCT/US2019/055850 WO2020077217A1 (en) | 2018-10-11 | 2019-10-11 | Prodrug modulators of the integrated stress pathway |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022209518A Division JP2023040106A (ja) | 2018-10-11 | 2022-12-27 | 統合的ストレス経路のプロドラッグ調節剤 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022504638A JP2022504638A (ja) | 2022-01-13 |
| JPWO2020077217A5 JPWO2020077217A5 (https=) | 2022-10-19 |
| JP2022504638A5 true JP2022504638A5 (https=) | 2022-10-19 |
| JP7203964B2 JP7203964B2 (ja) | 2023-01-13 |
Family
ID=68387427
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519747A Active JP7203964B2 (ja) | 2018-10-11 | 2019-10-11 | 統合的ストレス経路のプロドラッグ調節剤 |
| JP2022209518A Pending JP2023040106A (ja) | 2018-10-11 | 2022-12-27 | 統合的ストレス経路のプロドラッグ調節剤 |
| JP2025027546A Pending JP2025081607A (ja) | 2018-10-11 | 2025-02-25 | 統合的ストレス経路のプロドラッグ調節剤 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022209518A Pending JP2023040106A (ja) | 2018-10-11 | 2022-12-27 | 統合的ストレス経路のプロドラッグ調節剤 |
| JP2025027546A Pending JP2025081607A (ja) | 2018-10-11 | 2025-02-25 | 統合的ストレス経路のプロドラッグ調節剤 |
Country Status (35)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3071024A1 (en) | 2017-08-09 | 2019-02-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| CN111201245B (zh) | 2017-09-01 | 2024-04-05 | 戴纳立制药公司 | 化合物、组合物和方法 |
| WO2019090088A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| CN111757739A (zh) | 2017-12-13 | 2020-10-09 | 普拉西斯生物技术有限责任公司 | 整合应激反应路径抑制剂 |
| AU2019282253A1 (en) | 2018-06-05 | 2020-11-26 | Altos Labs, Inc. | Inhibitors of integrated stress response pathway |
| TW202545902A (zh) * | 2018-10-11 | 2025-12-01 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
| EP3924341A4 (en) | 2019-02-13 | 2022-11-02 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| SG11202108552QA (en) | 2019-02-13 | 2021-09-29 | Denali Therapeutics Inc | Compounds, compositions and methods |
| WO2020252207A1 (en) | 2019-06-12 | 2020-12-17 | Praxis Biotech LLC | Modulators of integrated stress response pathway |
| CN115190813B (zh) | 2020-03-11 | 2024-10-15 | 埃沃特克国际有限责任公司 | 整合应激反应途径的调节剂 |
| EP4232447A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| RS66455B1 (sr) | 2020-10-22 | 2025-02-28 | Evotec Int Gmbh | Modulatori puta integrisanog odgovora na stres |
| EP4232153A1 (en) | 2020-10-22 | 2023-08-30 | Evotec International GmbH | Modulators of the integrated stress response pathway |
| US12416736B2 (en) | 2020-11-13 | 2025-09-16 | National University Corporation Shizuoka University | Radiographic device |
| AU2021407138A1 (en) * | 2020-12-25 | 2023-06-29 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Use of nk1 antagonist prodrug compound in combination with 5-ht3 receptor antagonist |
| US12492178B2 (en) | 2021-09-01 | 2025-12-09 | Empathbio, Inc. | Stable polymorph of R-MDMA HCl |
| MX2024002291A (es) | 2021-09-01 | 2024-06-28 | Empathbio Inc | Sintesis de mdma o sus isomeros de mdma opticamente activos (r)- o (s). |
| WO2023056102A1 (en) | 2021-10-01 | 2023-04-06 | ATAI Life Sciences AG | Novel prodrugs of mdma, mda, and derivatives thereof |
| US11912680B2 (en) | 2021-12-28 | 2024-02-27 | Empathbio, Inc. | Nitric oxide releasing prodrugs of MDA and MDMA |
| WO2025230528A1 (en) * | 2024-05-01 | 2025-11-06 | Calico Life Sciences Llc | Methods of treating amyotrophic lateral sclerosis |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5212A (en) | 1847-07-31 | Richard m | ||
| US162A (en) | 1837-04-17 | Island | ||
| GB1026506A (en) | 1962-10-17 | 1966-04-20 | Du Pont | Bicyclodiamines and preparation thereof |
| US3264351A (en) | 1964-07-08 | 1966-08-02 | American Home Prod | 1, 4-diaminobicyclo [2.2.2] octanes |
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JPH02215779A (ja) | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | カルボン酸アミド誘導体類及びその医薬用途 |
| US5047406A (en) | 1989-12-06 | 1991-09-10 | Warner-Lambert Co. | Substituted cyclohexanols as central nervous system agents |
| ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
| CA2166974A1 (en) | 1993-07-16 | 1995-01-26 | Mark G. Bock | Substituted amide derivatives of piperizinylcamphor sulfonyl and carbonyl oxytocin antagonists |
| US7091380B2 (en) | 2002-02-08 | 2006-08-15 | Merck & Co., Inc. | N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| TWI259079B (en) | 2002-02-08 | 2006-08-01 | Merck & Co Inc | N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives |
| WO2004052862A1 (ja) | 2002-12-10 | 2004-06-24 | Ono Pharmaceutical Co., Ltd. | 含窒素複素環化合物およびその医薬用途 |
| JO2397B1 (en) | 2002-12-20 | 2007-06-17 | ميرك شارب اند دوم كوربوريشن | Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors |
| CA2517034A1 (en) * | 2003-03-13 | 2004-09-30 | Synta Pharmaceuticals Corp. | Fused pyrrole compounds |
| JP2007517868A (ja) | 2004-01-07 | 2007-07-05 | アストラゼネカ アクチボラグ | 治療薬ｉ |
| WO2005077900A1 (ja) | 2004-02-18 | 2005-08-25 | Kyorin Pharmaceutical Co., Ltd. | ビシクロアミド誘導体 |
| JP5133702B2 (ja) | 2005-01-05 | 2013-01-30 | アボット・ラボラトリーズ | １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型酵素の阻害薬 |
| BRPI0614290A2 (pt) | 2005-08-08 | 2011-03-22 | Argenta Discovery Ltd | derivados de biciclo [ 2.2.1 ] hept-7-ilamina e seus usos |
| EP2121626A1 (en) | 2006-12-15 | 2009-11-25 | Pfizer Products Inc. | Benzimidazole derivatives |
| US8815872B2 (en) | 2008-09-08 | 2014-08-26 | Merck Patent Gmbh | Macrocyclics pyrimidines as aurora kinase inhibitors |
| HRP20090186A2 (hr) | 2009-03-31 | 2010-10-31 | Institut Ruđer Bošković | Adamantanski bisureidni derivati, metoda priprave i primjena u detekciji aniona |
| WO2011087758A1 (en) | 2009-12-22 | 2011-07-21 | H. Lundbeck A/S | Adamantyl amide derivatives and uses of same |
| TWI538905B (zh) | 2010-12-22 | 2016-06-21 | Ｈ 朗德貝克公司 | 雙環［３．２．１］辛基醯胺衍生物及其用途 |
| WO2013161980A1 (ja) | 2012-04-27 | 2013-10-31 | 東レ株式会社 | シクロヘキサンジアミド誘導体及びその医薬用途 |
| CA2904794C (en) | 2013-03-15 | 2021-11-23 | Peter Walter | Modulators of the eif2alpha pathway |
| US9580459B2 (en) | 2013-04-26 | 2017-02-28 | Metselex, Inc. | Water-soluble ursodeoxycholic acid prodrugs |
| US20160318856A1 (en) | 2013-09-11 | 2016-11-03 | The Brigham And Women's Hospital, Inc. | Substituted Urea eIF2alpha Kinase Activators |
| CN106458990B (zh) | 2014-04-04 | 2019-06-07 | 希洛斯医药品股份有限公司 | 细胞周期蛋白依赖性激酶7(cdk7)的抑制剂 |
| US20150362847A1 (en) | 2014-06-13 | 2015-12-17 | Canon Kabushiki Kaisha | Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus |
| WO2016058544A1 (en) | 2014-10-16 | 2016-04-21 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| EA201792421A1 (ru) | 2015-05-05 | 2018-05-31 | Байер Фарма Акциенгезельшафт | Амидозамещенные производные циклогексана |
| US20190022071A1 (en) | 2015-08-31 | 2019-01-24 | Proteostasis Therapeutics, Inc. | Methods of treating pulmonary diseases and disorders |
| TW201722958A (zh) | 2015-09-15 | 2017-07-01 | 葛蘭素史克智慧財產（第二）有限公司 | 化學化合物 |
| TW201808903A (zh) * | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808914A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TW201808888A (zh) | 2016-05-05 | 2018-03-16 | 嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| TWI763668B (zh) * | 2016-05-05 | 2022-05-11 | 美商嘉來克生命科學有限責任公司 | 整合應激途徑之調節劑 |
| US20190298705A1 (en) | 2016-06-08 | 2019-10-03 | Glaxosmithkline Intellectual Property Development Limited | Chemical Compounds |
| CN109641910A (zh) | 2016-06-24 | 2019-04-16 | 梅尔莎纳医疗公司 | 吡咯并苯二氮*及其缀合物 |
| CN106349130B (zh) | 2016-08-25 | 2018-01-23 | 潍坊大有生物化工有限公司 | 一种新的氟苯尼考的合成方法 |
| WO2018225093A1 (en) | 2017-06-07 | 2018-12-13 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds as atf4 pathway inhibitors |
| CA3071024A1 (en) | 2017-08-09 | 2019-02-14 | Denali Therapeutics Inc. | Compounds, compositions and methods |
| HRP20251431T1 (hr) * | 2017-08-14 | 2026-01-02 | Prilenia Neurotherapeutics Ltd. | Liječenje amiotrofične lateralne skleroze pridopidinom |
| CN111201245B (zh) | 2017-09-01 | 2024-04-05 | 戴纳立制药公司 | 化合物、组合物和方法 |
| UY37957A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| JP2021501781A (ja) | 2017-11-02 | 2021-01-21 | カリコ ライフ サイエンシーズ エルエルシー | 統合的ストレス経路の調節剤 |
| UY37958A (es) | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| AU2018358157B2 (en) | 2017-11-02 | 2023-03-09 | Abbvie Inc. | Modulators of the integrated stress pathway |
| WO2019090088A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| CA3080808A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| WO2019090074A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| UY37956A (es) * | 2017-11-02 | 2019-05-31 | Abbvie Inc | Moduladores de la vía de estrés integrada |
| WO2019090090A1 (en) | 2017-11-02 | 2019-05-09 | Calico Life Sciences Llc | Modulators of the integrated stress pathway |
| WO2019183589A1 (en) | 2018-03-23 | 2019-09-26 | Denali Therapeutics Inc. | Modulators of eukaryotic initiation factor 2 |
| CN108517001A (zh) | 2018-05-17 | 2018-09-11 | 江苏恩华络康药物研发有限公司 | 水溶性别孕烯醇酮衍生物及其用途 |
| WO2020012339A1 (en) | 2018-07-09 | 2020-01-16 | Glaxosmithkline Intellectual Property Development Limited | Chemical compounds |
| TW202545902A (zh) * | 2018-10-11 | 2025-12-01 | 美商嘉來克生命科學有限責任公司 | 整合應激路徑之前藥調節劑 |
| SG11202111970WA (en) | 2019-04-30 | 2021-11-29 | Calico Life Sciences Llc | Substituted cyclolakyls as modulators of the integrated stress pathway |
| PE20220572A1 (es) | 2019-04-30 | 2022-04-20 | Calico Life Sciences Llc | Moduladores de la via integrada del estres |
-
2019
- 2019-10-09 TW TW114105524A patent/TW202545902A/zh unknown
- 2019-10-09 TW TW108136745A patent/TWI771621B/zh active
- 2019-10-09 TW TW111122712A patent/TWI832295B/zh active
- 2019-10-09 TW TW112140853A patent/TWI877863B/zh active
- 2019-10-11 PE PE2021000488A patent/PE20211277A1/es unknown
- 2019-10-11 LT LTEPPCT/US2019/055850T patent/LT3864003T/lt unknown
- 2019-10-11 AU AU2019356565A patent/AU2019356565B2/en active Active
- 2019-10-11 FI FIEP19795413.4T patent/FI3864003T3/fi active
- 2019-10-11 IL IL321549A patent/IL321549A/en unknown
- 2019-10-11 ES ES19795413T patent/ES2938061T3/es active Active
- 2019-10-11 MX MX2021004163A patent/MX2021004163A/es unknown
- 2019-10-11 HR HRP20230222TT patent/HRP20230222T1/hr unknown
- 2019-10-11 AR ARP190102911A patent/AR116693A1/es not_active Application Discontinuation
- 2019-10-11 CN CN202211415030.XA patent/CN116283647A/zh active Pending
- 2019-10-11 KR KR1020257034351A patent/KR20250153325A/ko active Pending
- 2019-10-11 RS RS20230160A patent/RS64013B1/sr unknown
- 2019-10-11 UY UY0001038415A patent/UY38415A/es not_active Application Discontinuation
- 2019-10-11 SI SI201930432T patent/SI3864003T1/sl unknown
- 2019-10-11 MD MDE20210768T patent/MD3864003T2/ro unknown
- 2019-10-11 SM SM20230058T patent/SMT202300058T1/it unknown
- 2019-10-11 CR CR20230182A patent/CR20230182A/es unknown
- 2019-10-11 MA MA53861A patent/MA53861B1/fr unknown
- 2019-10-11 PE PE2023001965A patent/PE20241068A1/es unknown
- 2019-10-11 CN CN201980080430.XA patent/CN113423685B/zh active Active
- 2019-10-11 MY MYPI2021001892A patent/MY207223A/en unknown
- 2019-10-11 WO PCT/US2019/055850 patent/WO2020077217A1/en not_active Ceased
- 2019-10-11 EP EP25219299.2A patent/EP4714961A2/en active Pending
- 2019-10-11 PL PL19795413.4T patent/PL3864003T3/pl unknown
- 2019-10-11 IL IL300799A patent/IL300799B2/en unknown
- 2019-10-11 IL IL282153A patent/IL282153B2/en unknown
- 2019-10-11 EP EP19795413.4A patent/EP3864003B1/en active Active
- 2019-10-11 KR KR1020217013975A patent/KR102464077B1/ko active Active
- 2019-10-11 SG SG11202103531YA patent/SG11202103531YA/en unknown
- 2019-10-11 HU HUE19795413A patent/HUE061297T2/hu unknown
- 2019-10-11 DK DK19795413.4T patent/DK3864003T3/da active
- 2019-10-11 KR KR1020227038367A patent/KR20220151232A/ko not_active Ceased
- 2019-10-11 CA CA3115668A patent/CA3115668A1/en active Pending
- 2019-10-11 PT PT197954134T patent/PT3864003T/pt unknown
- 2019-10-11 EP EP22210424.2A patent/EP4209483B1/en active Active
- 2019-10-11 JP JP2021519747A patent/JP7203964B2/ja active Active
-
2021
- 2021-04-08 PH PH12021550786A patent/PH12021550786A1/en unknown
- 2021-04-09 MX MX2023009561A patent/MX2023009561A/es unknown
- 2021-04-09 DO DO2021000064A patent/DOP2021000064A/es unknown
- 2021-04-09 CL CL2021000875A patent/CL2021000875A1/es unknown
- 2021-04-09 US US17/227,071 patent/US11149043B2/en active Active
- 2021-05-10 EC ECSENADI202132861A patent/ECSP21032861A/es unknown
- 2021-05-11 CO CONC2021/0006098A patent/CO2021006098A2/es unknown
- 2021-09-02 US US17/446,807 patent/US20220251123A1/en active Pending
-
2022
- 2022-04-07 AR ARP220100871A patent/AR125309A2/es unknown
- 2022-12-27 JP JP2022209518A patent/JP2023040106A/ja active Pending
-
2024
- 2024-01-02 AU AU2024200013A patent/AU2024200013B2/en active Active
-
2025
- 2025-02-25 JP JP2025027546A patent/JP2025081607A/ja active Pending